HighTower Advisors’s Tema Oncology ETF CANC Stock Holding History
Bought
Maintained
Sold
Other funds holding CANC
HighTower Advisors's CANC Position: Q3 2026 in Review
HighTower Advisors increased its Tema Oncology ETF (CANC) stake by 27% in Q3 2026, buying an estimated $879K and bringing the position to 97,197 shares worth $4.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1381.
HighTower Advisors first reported a position in CANC in Q1 2026 and has held it in 3 quarters since. 17 funds tracked by Wall St. Rank hold CANC as of Q3 2026.
- HighTower Advisors held 97,197 shares of Tema Oncology ETF worth $4.08M as of Q3 2026.
- HighTower Advisors bought 20,796 Tema Oncology ETF shares in Q3 2026, an estimated $879K.
- Tema Oncology ETF made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #1381 holding.
- HighTower Advisors first reported a position in Tema Oncology ETF in Q1 2026 and has held it in 3 quarters since.
- 17 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q3 2026.
Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.